Sanofi India Limited (SANOFI.NS) Income Statement Analysis

See more : HMZ Metals, Inc. (HMZMF) Income Statement Analysis – Financial Results

Complete financial analysis of Sanofi India Limited (SANOFI.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sanofi India Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.

You may be interested

Sanofi India Limited (SANOFI.NS)

Industry: Drug Manufacturers - General

Sector: Healthcare

Website: https://www.sanofiindialtd.com

About Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue	28.51B	27.70B	29.25B	28.69B	30.14B	27.42B	24.70B	23.42B	21.76B	19.64B	18.01B	15.69B	12.30B	10.85B	9.74B	9.83B	8.74B	8.84B	8.08B	7.35B
Cost of Revenue	12.57B	11.90B	13.07B	12.54B	13.47B	11.46B	10.32B	10.67B	10.15B	9.76B	8.21B	7.39B	6.19B	5.39B	4.82B	4.76B	4.23B	4.29B	3.75B	3.30B
Gross Profit	15.94B	15.81B	16.18B	16.15B	16.66B	15.96B	14.38B	12.75B	11.61B	9.88B	9.80B	8.30B	6.10B	5.46B	4.92B	5.07B	4.51B	4.55B	4.32B	4.05B
Gross Profit Ratio	55.90%	57.06%	55.32%	56.30%	55.29%	58.21%	58.22%	54.45%	53.36%	50.31%	54.41%	52.93%	49.63%	50.32%	50.54%	51.56%	51.63%	51.51%	53.52%	55.07%
Research & Development	6.00M	2.00M	4.00M	3.00M	3.00M	100.00M	77.52M	82.00M	45.90M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	3.72B	749.00M	804.00M	750.00M	817.00M	784.00M	741.00M	652.00M	570.90M	491.90M	161.50M	164.40M	0.00	1.04B	1.13B	1.48B	1.34B	1.18B	1.34B	1.28B
Selling & Marketing	409.00M	1.68B	1.60B	1.68B	2.00B	1.96B	1.83B	1.55B	1.53B	1.41B	1.81B	1.58B	0.00	1.70B	1.38B	811.46M	672.31M	581.84M	247.40M	234.09M
SG&A	4.13B	2.43B	2.40B	2.43B	2.82B	2.74B	2.57B	2.20B	2.10B	1.90B	1.97B	1.75B	0.00	2.74B	2.51B	2.29B	2.01B	1.76B	1.59B	1.52B
Other Expenses	0.00	6.75B	6.82B	7.38B	8.17B	7.99B	20.00M	16.00M	15.00M	113.70M	118.70M	116.20M	3.27B	-29.89M	-1.01M	-187.27M	272.12M	282.81M	364.42M	337.38M
Operating Expenses	4.13B	9.18B	9.22B	9.82B	10.99B	10.74B	10.02B	8.72B	8.13B	7.41B	6.74B	6.08B	3.27B	3.06B	2.51B	2.10B	2.28B	2.05B	1.96B	1.85B
Cost & Expenses	16.32B	21.08B	22.29B	22.35B	24.47B	22.20B	20.34B	19.39B	18.28B	17.17B	14.95B	13.47B	9.46B	8.45B	7.33B	6.86B	6.51B	6.33B	5.71B	5.16B
Interest Income	475.00M	589.00M	631.00M	780.00M	910.00M	789.00M	721.00M	605.00M	488.60M	505.90M	328.90M	284.50M	538.70M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	17.00M	17.00M	18.00M	18.00M	3.00M	7.00M	11.00M	15.00M	4.00M	4.80M	4.20M	14.00M	4.16M	28.90M	743.00K	3.41M	1.92M	1.82M	459.00K	994.00K
Depreciation & Amortization	396.00M	419.00M	667.00M	822.00M	999.00M	1.03B	1.02B	1.19B	1.13B	966.40M	922.60M	898.70M	311.45M	197.36M	173.44M	182.14M	184.54M	178.47M	171.81M	168.39M
EBITDA	8.87B	9.08B	13.26B	7.61B	7.00B	7.13B	6.17B	5.99B	5.10B	3.56B	4.16B	3.52B	3.15B	2.54B	2.59B	2.78B	2.37B	2.64B	2.51B	2.36B
EBITDA Ratio	31.10%	28.01%	28.39%	28.08%	25.26%	26.07%	25.07%	25.56%	23.49%	20.46%	24.97%	22.50%	25.73%	23.65%	26.59%	28.35%	27.64%	30.37%	31.43%	32.15%
Operating Income	12.19B	7.34B	7.64B	7.24B	6.61B	6.12B	5.17B	4.67B	3.98B	3.05B	3.57B	2.63B	2.85B	2.37B	2.42B	2.61B	2.23B	2.51B	2.37B	2.19B
Operating Income Ratio	42.77%	26.50%	26.11%	25.22%	21.95%	22.33%	20.93%	19.96%	18.30%	15.54%	19.85%	16.77%	23.19%	21.83%	24.81%	26.50%	25.53%	28.35%	29.30%	29.86%
Total Other Income/Expenses	-3.74B	-2.59B	1.09B	-4.29B	326.00M	872.00M	783.00M	641.00M	-12.00M	-3.17B	509.30M	-14.40M	-12.52M	-20.54M	-3.17M	-8.16M	-1.92M	-8.79M	-3.09M	67.08M
Income Before Tax	8.46B	8.64B	12.58B	6.77B	6.00B	6.10B	5.15B	4.66B	3.97B	3.06B	3.63B	2.62B	2.84B	2.34B	2.41B	2.60B	2.23B	2.50B	2.36B	2.26B
Income Before Tax Ratio	29.66%	31.20%	43.00%	23.61%	19.91%	22.24%	20.83%	19.90%	18.25%	15.58%	20.16%	16.68%	23.09%	21.57%	24.78%	26.41%	25.51%	28.25%	29.26%	30.78%
Income Tax Expense	2.43B	2.44B	3.13B	2.00B	1.86B	2.29B	1.89B	1.69B	1.59B	1.09B	1.23B	850.50M	743.17M	789.91M	840.45M	934.44M	784.17M	804.13M	913.06M	777.02M
Net Income	6.03B	6.21B	9.44B	4.78B	4.14B	3.81B	3.26B	2.97B	3.21B	2.64B	2.65B	1.77B	1.91B	1.55B	1.57B	1.66B	1.44B	1.69B	1.45B	1.48B
Net Income Ratio	21.15%	22.40%	32.29%	16.65%	13.74%	13.88%	13.20%	12.68%	14.77%	13.42%	14.72%	11.26%	15.55%	14.29%	16.15%	16.90%	16.53%	19.15%	17.96%	20.20%
EPS	261.78	269.47	410.06	207.38	179.85	165.26	141.74	132.09	139.59	114.46	115.14	76.71	83.01	100.19	68.35	72.16	62.71	73.51	63.00	64.48
EPS Diluted	261.78	269.47	410.06	207.38	179.85	165.26	141.74	132.09	139.59	114.46	115.14	76.71	83.01	100.19	68.35	72.16	62.71	73.51	63.00	64.48
Weighted Avg Shares Out	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M
Weighted Avg Shares Out (Dil)	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M	23.03M

No news found for: SANOFI.NS

Source: https://incomestatements.info
Category: Stock Reports

Sanofi India Limited (SANOFI.NS) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories